CAS 16727-44-9: 3,5-Dibromo-2,6-dimethoxypyridine, 99%
Formula:C7H7Br2NO2
InChI:InChI=1/C7H7Br2NO2/c1-11-6-4(8)3-5(9)7(10-6)12-2/h3H,1-2H3
- Synonyms:
- 3,5-Dibromo-2,6-Dimethoxy-Pyridine
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 3,5-Dibromo-2,6-dimethoxypyridine REF: IN-DA003IKUCAS: 16727-44-9 | 98% | To inquire | Tue 04 Mar 25 |
 | 3,5-Dibromo-2,6-dimethoxypyridine REF: 10-F462405CAS: 16727-44-9 | 95.0% | 32.00 €~719.00 € | Wed 05 Mar 25 |
 | 3,5-Dibromo-2,6-dimethoxypyridine REF: 54-OR302296CAS: 16727-44-9 | By hplc: 99.83% (Typical Value in Batch COA) | 135.00 €~253.00 € | Tue 11 Mar 25 |
 | 3,5-Dibromo-2,6-dimethoxypyridine REF: 3D-RAA72744CAS: 16727-44-9 | Min. 95% | - - - | Discontinued product |
3,5-Dibromo-2,6-dimethoxypyridine
CAS:16727-44-9
Formula:
C7H7Br2NO2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
296.9440
Ref: IN-DA003IKU
| 1g | 53.00 € | ||
| 5g | 102.00 € | ||
| 10g | 189.00 € | ||
| 25g | 214.00 € | ||
| 100g | To inquire | ||
| 250mg | 28.00 € |
Estimated delivery in United States, on Tuesday 4 Mar 2025
Ref: 10-F462405
| 1g | 32.00 € | ||
| 5g | 76.00 € | ||
| 10g | 139.00 € | ||
| 25g | 201.00 € | ||
| 100g | 719.00 € |
Estimated delivery in United States, on Wednesday 5 Mar 2025
3,5-Dibromo-2,6-dimethoxypyridine
CAS:16727-44-9
Formula:
C7H7Br2NO2
Purity:
By hplc: 99.83% (Typical Value in Batch COA)
Color and Shape:
white to light yellow solid
Molecular weight:
296.94g/mol
Ref: 54-OR302296
| 5g | 135.00 € | ||
| 25g | 253.00 € |
Estimated delivery in United States, on Tuesday 11 Mar 2025
3,5-Dibromo-2,6-dimethoxypyridine
CAS:16727-44-9
3,5-Dibromo-2,6-dimethoxypyridine is a lead compound that has been shown to be effective against cancerous cells. …
Formula:
C7H7Br2NO2
Purity:
Min. 95%
Molecular weight:
296.95 g/mol
Ref: 3D-RAA72744
| 5g | Discontinued | Request information | |
| 10g | Discontinued | Request information | |
| 25g | Discontinued | Request information | |
| 50g | Discontinued | Request information | |
| 100g | Discontinued | Request information |
